Unknown

Dataset Information

0

Synthesis of caffeic acid amides bearing 2,3,4,5-tetra-hydrobenzo[b][1,4]dioxocine moieties and their biological evaluation as antitumor agents.

ABSTRACT: A series of caffeic acid amides D1-D17 bearing 2,3,4,5-tetrahydrobenzo-[b][1,4]dioxocine units has been synthesized and their biological activities evaluated for potential antiproliferative and EGFR inhibitory activity. Of all the compounds studied, compound D9 showed the most potent inhibitory activity (IC50=0.79 ?M for HepG2 and IC50=0.36 ?M for EGFR). The structures of compounds were confirmed by 1H-NMR, ESI-MS and elemental analysis. Among all, the structure of compound D9 ((E)-N-(4-ethoxyphenyl)-3-(2,3,4,5-tetrahydrobenzo[b][1,4]dioxocin-8-yl)acrylamide) was also determined by single-crystal X-ray diffraction analysis. Compound D9 was found to be a potential antitumor agent according to biological activity, molecular docking, apoptosis assay and inhibition of HepG2.

SUBMITTER: Yuan JW 

PROVIDER: S-EPMC6271756 | biostudies-literature | 2014 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Synthesis of caffeic acid amides bearing 2,3,4,5-tetra-hydrobenzo[b][1,4]dioxocine moieties and their biological evaluation as antitumor agents.

Yuan Ji-Wen JW   Qiu Han-Yue HY   Wang Peng-Fei PF   Makawana Jigar A JA   Yang Yong-An YA   Zhang Fei F   Yin Yong Y   Lin Jie J   Wang Zhong-Chang ZC   Zhu Hai-Liang HL  

Molecules (Basel, Switzerland) 20140603 6

A series of caffeic acid amides D1-D17 bearing 2,3,4,5-tetrahydrobenzo-[b][1,4]dioxocine units has been synthesized and their biological activities evaluated for potential antiproliferative and EGFR inhibitory activity. Of all the compounds studied, compound D9 showed the most potent inhibitory activity (IC50=0.79 μM for HepG2 and IC50=0.36 μM for EGFR). The structures of compounds were confirmed by 1H-NMR, ESI-MS and elemental analysis. Among all, the structure of compound D9 ((E)-N-(4-ethoxyph  ...[more]

Similar Datasets

Unknown 4-Acetyl-2,3,4,5-tetra-hydro-1H-1,4-benzodiazepine.
| S-EPMC2961359 | biostudies-literature
Unknown Synthesis and biological evaluation of ursolic acid derivatives bearing triazole moieties as potential anti-Toxoplasma gondii agents.
| S-EPMC6407578 | biostudies-literature
Unknown Crystal structure of 2,2,4-trimethyl-2,3,4,5-tetra-hydro-1H-benzo[b][1,4]diazepine hemihydrate.
| S-EPMC4571402 | biostudies-literature
Unknown 3,3,4,4-Tetra-fluoro-2,3,4,5-tetra-hydro-1,6-benzodioxocine-8-carbaldehyde.
| S-EPMC2979198 | biostudies-literature
Unknown Synthesis and Spectroscopic Identification of Certain Imidazole-Semicarbazone Conjugates Bearing Benzodioxole Moieties: New Antifungal Agents.
| S-EPMC6337076 | biostudies-literature
Unknown Tetra-methyl 1,1,2-triphenyl-2H-1λ-phosphole-2,3,4,5-tetra-carboxyl-ate.
| S-EPMC3008977 | biostudies-literature
Unknown Natural inspired piperine-based ureas and amides as novel antitumor agents towards breast cancer.
| S-EPMC8667897 | biostudies-literature
Unknown 4,5,6,7-Tetra-bromo-1,1,3-trimethyl-3-(2,3,4,5-tetra-bromo-phen-yl)indane.
| S-EPMC2960393 | biostudies-literature
Unknown 2,3,4,5-Tetra-fluoro-benzoic acid-4,4'-bipyridine (2/1).
| S-EPMC2977157 | biostudies-literature
Unknown tert-Butyl-ammonium 2,3,4,5-tetra-chloro-6-methoxy-carbonyl-benzoate.
| S-EPMC2959952 | biostudies-literature